Express Scripts Holding Company (NASDAQ: ESRX) recently received a number of ratings updates from brokerages and research firms:
Express Scripts Holding Company (NASDAQ:ESRX) traded down 1.8907% on Friday, hitting $59.5131. 3,870,083 shares of the company traded hands. The stock’s 50-day moving average is $64.36 and its 200 day moving average is $69.09. The stock has a market cap of $35.32 billion, a PE ratio of 10.7892 and a beta of 0.92. Express Scripts Holding Company has a 12 month low of $57.80 and a 12 month high of $80.02.
Express Scripts Holding Company (NASDAQ:ESRX) last released its quarterly earnings data on Monday, April 24th. The company reported $1.33 EPS for the quarter, topping analysts’ consensus estimates of $1.32 by $0.01. The firm had revenue of $24.65 billion for the quarter, compared to the consensus estimate of $24.95 billion. Express Scripts Holding Company had a net margin of 2.70% and a return on equity of 24.99%. The firm’s revenue was down .6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.22 earnings per share. Equities research analysts expect that Express Scripts Holding Company will post $6.97 earnings per share for the current fiscal year.
In related news, SVP Everett Neville sold 2,352 shares of the business’s stock in a transaction dated Wednesday, March 1st. The shares were sold at an average price of $70.16, for a total transaction of $165,016.32. Following the sale, the senior vice president now owns 11,287 shares of the company’s stock, valued at $791,895.92. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.54% of the stock is currently owned by insiders.
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).